Despite this negative result, our three different translational approaches including patient HCC qPCR and IHC analyses as well as the patient HCC organoid study, consistently supported the relevance and functionality of the LTB4R2 pathway. Here, LTB4R2 is linked to hepatocellular carcinoma.